 |
PDBsum entry 4boh
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/inhibitor
|
PDB id
|
|
|
|
4boh
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/inhibitor
|
 |
|
Title:
|
 |
Madanins (merops i53) are cleaved by thrombin and factor xa
|
|
Structure:
|
 |
Thrombin heavy chain. Chain: a, h. Synonym: alpha-thrombin, coagulation factor ii,. Thrombin light chain. Chain: b, l. Synonym: alpha-thrombin, coagulation factor ii. Thrombin inhibitor madanin 1. Chain: m. Fragment: residues 20-79.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Tissue: plasma. Haemaphysalis longicornis. Organism_taxid: 44386. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Resolution:
|
 |
|
2.60Å
|
R-factor:
|
0.193
|
R-free:
|
0.239
|
|
|
Authors:
|
 |
A.C.Figueiredo,D.Desanctis,P.J.B.Pereira
|
|
Key ref:
|
 |
A.C.Figueiredo
et al.
(2013).
The tick-derived anticoagulant madanin is processed by thrombin and factor Xa.
Plos One,
8,
e71866.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
20-May-13
|
Release date:
|
04-Sep-13
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P00734
(THRB_HUMAN) -
Prothrombin from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
622 a.a.
249 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B, H, L:
E.C.3.4.21.5
- thrombin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Preferential cleavage: Arg-|-Gly; activates fibrinogen to fibrin and releases fibrinopeptide A and B.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Plos One
8:e71866
(2013)
|
|
PubMed id:
|
|
|
|
|
| |
|
The tick-derived anticoagulant madanin is processed by thrombin and factor Xa.
|
|
A.C.Figueiredo,
D.de Sanctis,
P.J.Pereira.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The cysteine-less peptidic anticoagulants madanin-1 and madanin-2 from the bush
tick Haemaphysalis longicornis are the founding members of the MEROPS inhibitor
family I53. It has been previously suggested that madanins exert their
functional activity by competing with physiological substrates for binding to
the positively charged exosite I (fibrinogen-binding exosite) of α-thrombin. We
hereby demonstrate that competitive inhibition of α-thrombin by madanin-1 or
madanin-2 involves binding to the enzyme's active site. Moreover, the blood
coagulation factors IIa and Xa are shown to hydrolyze both inhibitors at
different, although partially overlapping cleavage sites. Finally, the
three-dimensional structure of the complex formed between human α-thrombin and
a proteolytic fragment of madanin-1, determined by X-ray crystallography,
elucidates the molecular details of madanin-1 recognition and processing by the
proteinase. Taken together, the current findings establish the mechanism of
action of madanins, natural anticoagulants that behave as cleavable competitive
inhibitors of thrombin.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
| |